Cracking the Code: How Nano-Informatics is Crafting Intelligent Nano-Weapons to Outsmart Multiple Drug Resistance (MDR).

Q2 Pharmacology, Toxicology and Pharmaceutics
Priyanka Sinoliya, Ravi Ranjan Kumar Niraj, Vinay Sharma
{"title":"Cracking the Code: How Nano-Informatics is Crafting Intelligent Nano-Weapons to Outsmart Multiple Drug Resistance (MDR).","authors":"Priyanka Sinoliya, Ravi Ranjan Kumar Niraj, Vinay Sharma","doi":"10.2174/0122117385383102250818052847","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Multiple Drug Resistance (MDR) is one of the prime concerns globally in the health sector. The emergence and proliferation of ESKAPE pathogens, along with drug resistance in cancer cells, represent a significant challenge to public health, emphasizing the need for novel therapeutics, improved infection control practices, and ongoing research to understand and combat antibiotic resistance. Addressing multiple drug resistance involves several modern therapeutic strategies, such as phage therapy, immunotherapy, combinatorial therapy, and more. Advanced diagnostic tools, effective control measures, and stringent regulatory and policy initiatives raising public awareness are also crucial.</p><p><strong>Methods: </strong>This study scouted computational approaches, focusing on their application in nanotechnology and nano-drug systems in clinical settings. A systematic approach was employed to gather, screen, and critically analyze the relevant literature for this review.</p><p><strong>Results: </strong>This study found that various tools and databases are evolving for reconnaissance in the field of nano-informatics, which will lead to research and development.</p><p><strong>Discussion: </strong>This study highlights the rapid advancement of nano-informatics tools and databases, which are crucial for advancing computational approaches in nanomedicine and therapeutic research. These emerging resources support predictive analysis and integration with biological datasets, though challenges remain in data standardization, accessibility, and interoperability across platforms.</p><p><strong>Conclusion: </strong>To mitigate multiple drug resistance, researchers are exploring various approaches, and nano-informatics can provide new insight into dealing with it. This approach will advance the development of medical devices, drug design, and delivery systems.</p>","PeriodicalId":19774,"journal":{"name":"Pharmaceutical nanotechnology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical nanotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0122117385383102250818052847","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Multiple Drug Resistance (MDR) is one of the prime concerns globally in the health sector. The emergence and proliferation of ESKAPE pathogens, along with drug resistance in cancer cells, represent a significant challenge to public health, emphasizing the need for novel therapeutics, improved infection control practices, and ongoing research to understand and combat antibiotic resistance. Addressing multiple drug resistance involves several modern therapeutic strategies, such as phage therapy, immunotherapy, combinatorial therapy, and more. Advanced diagnostic tools, effective control measures, and stringent regulatory and policy initiatives raising public awareness are also crucial.

Methods: This study scouted computational approaches, focusing on their application in nanotechnology and nano-drug systems in clinical settings. A systematic approach was employed to gather, screen, and critically analyze the relevant literature for this review.

Results: This study found that various tools and databases are evolving for reconnaissance in the field of nano-informatics, which will lead to research and development.

Discussion: This study highlights the rapid advancement of nano-informatics tools and databases, which are crucial for advancing computational approaches in nanomedicine and therapeutic research. These emerging resources support predictive analysis and integration with biological datasets, though challenges remain in data standardization, accessibility, and interoperability across platforms.

Conclusion: To mitigate multiple drug resistance, researchers are exploring various approaches, and nano-informatics can provide new insight into dealing with it. This approach will advance the development of medical devices, drug design, and delivery systems.

破解密码:纳米信息学如何制造智能纳米武器以战胜多重耐药性(MDR)。
导言:耐多药(MDR)是全球卫生部门主要关注的问题之一。ESKAPE病原体的出现和增殖,以及癌细胞中的耐药性,对公共卫生构成了重大挑战,强调需要新的治疗方法,改进感染控制措施,以及正在进行的研究,以了解和对抗抗生素耐药性。解决多重耐药性涉及几种现代治疗策略,如噬菌体治疗、免疫治疗、联合治疗等。先进的诊断工具、有效的控制措施以及提高公众意识的严格监管和政策举措也至关重要。方法:本研究探索了计算方法,重点研究了它们在纳米技术和纳米药物系统中的临床应用。本综述采用系统方法收集、筛选和批判性分析相关文献。结果:本研究发现,纳米信息学领域的各种工具和数据库正在不断发展,这将导致研究和发展。讨论:这项研究突出了纳米信息学工具和数据库的快速发展,这对于推进纳米医学和治疗研究的计算方法至关重要。这些新兴资源支持预测分析和与生物数据集的集成,尽管在数据标准化、可访问性和跨平台互操作性方面仍然存在挑战。结论:为了减轻多重耐药,研究人员正在探索各种方法,纳米信息学可以为解决多重耐药问题提供新的见解。这种方法将促进医疗设备、药物设计和输送系统的发展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pharmaceutical nanotechnology
Pharmaceutical nanotechnology Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
4.20
自引率
0.00%
发文量
46
期刊介绍: Pharmaceutical Nanotechnology publishes original manuscripts, full-length/mini reviews, thematic issues, rapid technical notes and commentaries that provide insights into the synthesis, characterisation and pharmaceutical (or diagnostic) application of materials at the nanoscale. The nanoscale is defined as a size range of below 1 µm. Scientific findings related to micro and macro systems with functionality residing within features defined at the nanoscale are also within the scope of the journal. Manuscripts detailing the synthesis, exhaustive characterisation, biological evaluation, clinical testing and/ or toxicological assessment of nanomaterials are of particular interest to the journal’s readership. Articles should be self contained, centred around a well founded hypothesis and should aim to showcase the pharmaceutical/ diagnostic implications of the nanotechnology approach. Manuscripts should aim, wherever possible, to demonstrate the in vivo impact of any nanotechnological intervention. As reducing a material to the nanoscale is capable of fundamentally altering the material’s properties, the journal’s readership is particularly interested in new characterisation techniques and the advanced properties that originate from this size reduction. Both bottom up and top down approaches to the realisation of nanomaterials lie within the scope of the journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信